Royal Bank of Canada
GENE

Royal Bank of Canada’s Genetic Technologies Ltd. GENE Stock Holding History

Royal Bank of Canada’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-200
Closed -$1K – 8024
2022
Q2 		$1K Buy
200
+198
+9,900% +$1.43K ﹤0.01% 7254
2022
Q1 		$0 Hold
2
– – ﹤0.01% 8122
2021
Q4 		$0 Sell
2
-598
-100% -$7.67K ﹤0.01% 7987
2021
Q3 		$9K Buy
+600
New +$10.3K ﹤0.01% 7014
2016
Q2 		– Sell
-425
Closed -$20K – 6566
2016
Q1 		$20K Buy
+425
New +$18.5K ﹤0.01% 5494

Other funds holding GENE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada's GENE Position: Q3 2022 in Review

Royal Bank of Canada sold out of Genetic Technologies Ltd. (GENE) in Q3 2022, closing a stake of 200 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in GENE in Q1 2016 and held it in 5 quarters. The position peaked at $20K in Q1 2016. 10 funds tracked by Wall St. Rank hold GENE as of Q3 2022.

  • Royal Bank of Canada reported no remaining Genetic Technologies Ltd. position as of Q3 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 200 Genetic Technologies Ltd. shares in Q3 2022, an estimated $1K.
  • Royal Bank of Canada first reported a position in Genetic Technologies Ltd. in Q1 2016 and held it in 5 quarters.
  • Royal Bank of Canada's Genetic Technologies Ltd. position peaked at $20K in Q1 2016.
  • 10 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q3 2022.

Based on Royal Bank of Canada's 13F filing for Q3 2022, filed 14 Nov 2022.